Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. See Cardiff Oncology, Inc. (CRDF) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades NasdaqCM - Nasdaq Real Time Price •. The stock price for Cardiff Oncology (NASDAQ: CRDF) is $ last updated September 6, at AM EDT. Q. Does Cardiff Oncology (CRDF) pay a dividend? A. CRDF / Cardiff Oncology, Inc. (NasdaqCM) - Forecast, Price Target, Estimates, Predictions ; Projected Stock Price. $ ↑%. Estimated share price by. The current price of CRDF is USD — it has decreased by −% in the past 24 hours. Watch Cardiff Oncology, Inc. stock price performance more closely on.
A high-level overview of Cardiff Oncology, Inc. (CRDF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is. The 10 analysts offering price forecasts for Cardiff Oncology have a median target of , with a high estimate of and a low estimate of The. Cardiff Oncology Inc Stock Forecast, Price Prediction charts · Cardiff Oncology Inc Forecast, Short-Term " CRDF" Stock Price Prognosis for Next Days · CRDF. To predict the price for CRDF in , we can extrapolate the AI price target. This approach projects CRDF's price to reach $ What is the CRDF price. According to the 3 analysts' twelve-month price targets for Cardiff Oncology, the average price target is $ The highest price target for CRDF is $ Cardiff Oncology, Inc. (CRDF) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Performance History Market Value Patterns Correlation Forecast · CRDF Stock, USD %. Cardiff Stock Forecast is based on your current time horizon. How much is Cardiff Oncology's stock price per share? (NASDAQ: CRDF) Cardiff Oncology stock price per share is $ today (as of Jul 12, ). · What is. In the next week, the price of CRDF is expected to increase by % and hit $ Cardiff Oncology Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CRDF updated stock price target summary.
Get Cardiff Oncology Inc (CRDF:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing. According to analysts, CRDF price target is USD with a max estimate of USD and a min estimate of USD. The current Cardiff Oncology [CRDF] share price is $ The Score for CRDF is 62, which is 24% above its historic median score of 50, and infers lower risk. The forecasts for Cardiff Oncology, Inc. (CRDF) range from a low of $7 to a high of $ The average price target represents a increase of $ from the last. Stock Price Forecast. The 2 analysts with month price forecasts for Cardiff Oncology stock have an average target of , with a low estimate of and a. CRDF | Complete Cardiff Oncology Inc. stock news by MarketWatch. View Cardiff Oncology stock price target cut to $9 from $14 at Maxim Group. Feb. View Cardiff Oncology, Inc. CRDF stock quote prices, financial information, real-time forecasts, and company news from CNN. The Wall Street analyst predicted that Cardiff Oncology's share price could reach $ by May 6, The average Cardiff Oncology stock price prediction.
Cardiff Oncology (CRDF) stock price prediction is 0 USD. The Cardiff Oncology stock forecast is 0 USD for August 15, Friday with technical analysis. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Cardiff Oncology Stock Forecast, CRDF stock price prediction. Price target in 14 days: USD. The best long-term & short-term Cardiff Oncology share. Stock price target for Cardiff Oncology Inc CRDF are on downside and on upside. Tomorrow Target 1, 3. Tomorrow Target 2, Tomorrow Target 3, Discover Cardiff Oncology's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.
As on 1st Aug CRDF STOCK Price closed @ and we RECOMMEND N/A for LONG-TERM with Stoploss of & N/A for SHORT-TERM with Stoploss of we also. Cardiff Oncology Analyst Ratings ; Total Analysts. 2 ; Consensus Rating. Strong Buy ; Price Target. $ ; Upside. +%. Cardiff Oncology Inc. CRDF. (Nasdaq - US). N/A. Follow · (%). in:usd•As of: Jul 18, UTC Based on the Cardiff Oncology Inc stock forecast from 1 analysts, the average analyst target price for Cardiff Oncology Inc is USD over the next 12 months. The forecast for CRDF extends through multiple years, with detailed projections for , , , , and even as far as These projections are based. The financial health and growth prospects of CRDF, demonstrate its potential to underperform the market. It currently has a Growth Score of D. Recent price.